[1] The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Wkly 2020;2(8):113 − 22. http://dx.doi.org/10.46234/ccdcw2020.032CrossRef
[2] Wu ZY, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020;323(13):1239 − 42. http://dx.doi.org/10.1001/jama.2020.2648CrossRef
[3] Zhou L, Wu ZY, Li ZJ, Zhang YP, McGoogan JM, Li Q, et al. One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China. Clin Infect Dis 2021;72(2):332 − 9. http://dx.doi.org/10.1093/cid/ciaa725CrossRef
[4] Li ZJ, Chen QL, Feng LZ, Rodewald L, Xia YY, Yu HL, et al. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet 2020;396(10243):63 − 70. http://dx.doi.org/10.1016/S0140-6736(20)31278-2CrossRef